Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Background Conventional meta-analyses have shown inconsistent results for efficacy of
second-generation antidepressants. We therefore did a multiple-treatments meta-analysis …
second-generation antidepressants. We therefore did a multiple-treatments meta-analysis …
Systematic review and guide to selection of selective serotonin reuptake inhibitors
JG Edwards, I Anderson - Drugs, 1999 - Springer
A meta-analysis of 20 short term comparative studies of 5 selective serotonin reuptake
inhibitors (SSRIs; citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline) has shown …
inhibitors (SSRIs; citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline) has shown …
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians
Background: Second-generation antidepressants dominate the management of major
depressive disorder, dysthymia, and subsyndromal depression. Evidence on the …
depressive disorder, dysthymia, and subsyndromal depression. Evidence on the …
Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system
O Spigset - Drug safety, 1999 - Springer
Objective The selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs)
are extensively used in the treatment of depression, panic disorder and obsessive …
are extensively used in the treatment of depression, panic disorder and obsessive …
Citalopram--a review of pharmacological and clinical effects.
K Bezchlibnyk-Butler, I Aleksic… - Journal of Psychiatry and …, 2000 - ncbi.nlm.nih.gov
OBJECTIVE: To provide clinicians with a critical evaluation of citalopram, a selective
serotonin reuptake inhibitor (SSRI) that has been available in Canada since March 1999 …
serotonin reuptake inhibitor (SSRI) that has been available in Canada since March 1999 …
Citalopram versus other anti‐depressive agents for depression
Background Recent US and UK clinical practice guidelines recommend that second‐
generation antidepressants should be considered amongst the best first‐line options when …
generation antidepressants should be considered amongst the best first‐line options when …
Comparative Risk for Harms of Second Generation Antidepressants: A Systematic Review and Meta Analysis
Background: Evidence indicates that only minor differences in efficacy exist among second-
generation antidepressants for the treatment of major depressive disorder (MDD). However …
generation antidepressants for the treatment of major depressive disorder (MDD). However …
[HTML][HTML] Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features
PA Marken, JS Munro - Primary care companion to the Journal of …, 2000 - ncbi.nlm.nih.gov
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression.
Although these drugs presumably have the same mechanism of action, they vary in several …
Although these drugs presumably have the same mechanism of action, they vary in several …
Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials
MB Keller - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Background: This review summarizes and evaluates clinical experience with citalopram, the
latest selective serotonin reuptake inhibitor (SSRI) to be approved for the treatment of …
latest selective serotonin reuptake inhibitor (SSRI) to be approved for the treatment of …
Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
S Noble, P Benfield - CNS drugs, 1997 - Springer
Synopsis Citalopram is a selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor
(SSRI) which has been evaluated primarily in the treatment of major depression. In well …
(SSRI) which has been evaluated primarily in the treatment of major depression. In well …